Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery
Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…
US market to dent India pharma earnings even as domestic growth remains firm
New Delhi: India’s pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of FY26, according to a report by…
Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
Biocon Pharma, a subsidiary of Biocon, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Dapagliflozin Tablets, 5 mg and 10 mg. The…
Healthcare, pharma sector to create 2-2.5 million new jobs by 2030
Mumbai, India’s healthcare and pharmaceutical sector is set to enter a capability-led growth phase, potentially creating 2 to 2.5 million new jobs by 2030, while 30 to 35 per cent…
Over 45% eye infection bacteria drug-resistant, study flags AMR threat
Hyderabad: A joint study by CSIR-Centre for Cellular and Molecular Biology (CCMB) and LV Prasad Eye Institute (LVPEI) has flagged a worrying rise in antimicrobial resistance (AMR) in eye infections,…
Lokayukta Police Launch Multi-City Raids on ADC; Rs 3.37 Crore in Disproportionate Assets Unearthed Across Karnataka
Mangaluru: In a significant anti-corruption drive, Karnataka Lokayukta police conducted simultaneous searches at multiple properties linked to Babu B N, Assistant Drug Controller in the office of the Regional Deputy Drug…
Alembic Pharma Gets USFDA Nod for Dapagliflozin
New Delhi: Alembic Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its generic version of dapagliflozin tablets used to control blood sugar…
On World Health Day ‘CAHO Na Patient Se Pyaar Hai’
Chennai hosts 3 Day International Conference CAHOCON on Patient Safety in Hospitals starting April 10 New Delhi: Patient safety in hospitals is a global concern, more so in India. It…
Supreme Court willing to understand Angst of Doctors regarding Consumer Protection Act
Listing of PIL by AHPI raises hope in the community New Delhi: The PIL (Public Interest Litigation) to examine Plea on Applicability of Consumer Protection Act to Medical Professionals is…
Aurobindo Pharma Board approves ₹800 cr share buyback plan
Generic drugmaker is proposing to buyback more than 54.23 lakh equity shares at ₹1,475 each, fixes April 17, 2026 as the record date Aurobindo Pharma’s Board has approved the generic…
